Coeptis Therapeutics Holdings, Inc. — All Filings
307 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
25-NSE
3
4
424B3
424B4
425
8-A12B
8-K
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
NT 10-K
NT 10-Q
POS AM
PRE 14A
S-1
S-1/A
S-1MEF
S-4
S-4/A
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| UPLOAD | — | 0000000000-20-008562 | Sep 11, 2020 | — |
| DRS/A | — | 0001213900-20-023298 | Aug 21, 2020 | — |
| DRS/A | — | 0001213900-20-005635 | Mar 6, 2020 | — |
| DRS/A | — | 0001213900-19-026969 | Dec 26, 2019 | — |
| DRS | — | 0001615774-19-002834 | Feb 21, 2019 | — |